M&A Deal Summary

Virbac Acquires Centrovet Laboratories

On November 23, 2012, Virbac acquired life science company Centrovet Laboratories

Acquisition Highlights
  • This is Virbac’s 2nd transaction in the Life Science sector.
  • This is Virbac’s 1st transaction in Chile.

M&A Deal Summary
Date 2012-11-23
Target Centrovet Laboratories
Sector Life Science
Buyer(s) Virbac
Deal Type Add-on Acquisition

Target

Centrovet Laboratories

Cerrillos, Chile
Centrovet Laboratories, Inc. specializes in the development and manufacture of salmon and trout vaccines.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Virbac

Carros, France
Category Company
Founded 1968
Sector Healthcare Services
Employees5,459
Revenue 1.2B EUR (2023)
DESCRIPTION

Virbac is an veterinarian independent pharmaceutical company. Virbac was founded in 1968 and is based in Carros, France.

DEAL STATS #
Overall 2 of 5
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 1 of 3
Country (Chile) 1 of 1
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-12 Pfizer - Veterinary Products

Australia

Virbac will acquire rights to a portfolio of livestock products historically marketed in Australia by Fort Dodge Animal Health for use in farm animals, primarily cattle and sheep.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-27 Eli Lilly - Sentinel and Spectrum Brands

Indianapolis, Indiana, United States

Virbac would acquire a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, customer lists and other assets, related to two major parasiticides for dogs: Sentinel® Flavor Tabs and Sentinel® Spectrum, currently marketed in the United States by Novartis Animal Health.

Buy $410M
Mergr

Product

Company

Legal